摘要It is well recognized that any disruptive innovation in medicine looks at first unfeasible and unacceptable.It has been the case for transcatheter aortic valve implantation (TAVI) as the project appeared totally unrealistic in the early 1990s.It is quite thrilling,therefore,to observe the current expansion of this technology worldwide,20 years after the birth of the concept and 10 years after the first-in-man TAVIprocedure performed in Rouen on April 16,2002.To date,more than 80 000 patients have benefitted from TAVIworldwide and the number is consistently increasing.
更多相关知识
- 浏览104
- 被引0
- 下载12

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



